Skip to main content

Market Overview

50 Stocks Moving In Tuesday's Mid-Day Session



  • Superconductor Technologies Inc. (NASDAQ: SCON) shares jumped 107.1% to $0.4079. Superconductor Technologies and Allied Integral United announced a merger agreement.
  • NuCana plc (NASDAQ: NCNA) shares climbed 38.9% to $8.02.
  • Omeros Corporation (NASDAQ: OMER) shares climbed 38.6% to $17.45 after the company reported Narsoplimab HSCT-TMA results surpassed the FDA-agreed efficacy threshold. The company also reported upbeat quarterly sales.
  • Digirad Corporation (NASDAQ: DRAD) shares rose 37.5% to $3.37.
  • GenMark Diagnostics, Inc. (NASDAQ: GNMK) gained 28.8% to $4.52 after the company reported Q4 earnings results.
  • Capstone Turbine Corporation (NASDAQ: CPST) surged 20% to $2.54.
  • KemPharm, Inc. (NASDAQ: KMPH) rose 16.2% to $0.38 after the company submitted KP415 NDA to the FDA for the treatment of ADHD.
  • Boingo Wireless Inc (NASDAQ: WIFI) rose 15.5% to $13.74 after the company reported Q4 earnings.
  • Inovio Pharmaceuticals, Inc. (NASDAQ: INO) gained 15.3% to $5.06. Inovio Pharmaceuticals announced an accelerated timeline Tuesday for the development of its INO-4800 vaccine targeting the COVID-19 virus. Inovio said it plans to have 1 million doses of the INO-4800 COVID-19 DNA vaccine produced by the end of 2020 either for an emergency or for further trials.
  • Metalla Royalty & Streaming Ltd. (NYSE: MTA) gained 15.1% to $5.40.
  • Trillium Therapeutics Inc. (NASDAQ: TRIL) rose 14.6% to $5.44 after surging over 26% on Monday.
  • Alpha Pro Tech, Ltd. (NYSE: APT) shares rose 14.6% to $18.33.
  • QIAGEN N.V. (NASDAQ: QGEN) shares rose 14.5% to $41.36. Thermo Fisher Scientific Inc. (NYSE: TMO) announced plans to acquire QIAGEN for 10.4 billion euros ($11.6 billion).
  • Gold Resource Corporation (NYSE: GORO) gained 14.4% to $4.93 after the company updated its proven & probable reserves.
  • DRDGOLD Limited (NYSE: DRD) gained 13.4% to $7.36.
  • Theratechnologies Inc. (NASDAQ: THTX) climbed 13.2% to $2.74.
  • Genworth Financial, Inc. (NYSE: GNW) rose 12.8% to $4.7150 after the company and China Oceanwide Holdings reached an agreement in principle with the New York State Department of Financial Services on conditions expected to facilitate reapproval of merger.
  • Limited (NYSE: WBAI) surged 12% to $6.05.
  • Homology Medicines, Inc. (NASDAQ: FIXX) rose 11.8% to $19.00.
  • Veeco Instruments Inc. (NASDAQ: VECO) gained 11.7% to $15.04. Stifel Nicolaus upgraded Veeco Instruments from Hold to Buy and raised the price target from $14 to $18.
  • AngloGold Ashanti Limited (NYSE: AU) climbed 11.6% to $20.62.
  • Autolus Therapeutics plc (NASDAQ: AUTL) rose 9.9% to $9.23.
  • Sterling Construction Company, Inc. (NASDAQ: STRL) gained 9.5% to $14.87 following strong quarterly sales.

Check out these big penny stock gainers and losers


  • China Pharma Holdings, Inc. (NYSE: CPHI) fell 28.1% to $0.82. China Pharma shares jumped 100% on Monday after the company announced a wash-free sanitizer in response to the coronavirus.
  • Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) fell 27.6% to $0.4438 after slipping over 11% on Monday.
  • Daxor Corporation (NYSE: DXR) dropped 24.2% to $10.80. Daxor shares rose 65.7% on Monday after the company said hospitals are using its blood volume analyzer to prevent coronavirus deaths.
  • InflaRx N.V. (NASDAQ: IFRX) shares declined 23.2% to $4.67.
  • Heat Biologics, Inc. (NASDAQ: HTBX) fell 19.4% to $0.6450. Heat Biologics shares jumped more than 142% on Monday after the Durham, North, Carolina-based biopharma company said in an SEC filing that it has filed a provisional patent application that would apply its immune system activating technology for the treatment or prevention ofCOVID-19, the new coronavirus originating from Wuhan, China.
  • Novan Inc (NASDAQ: NOVN) fell 18.8% to $0.3794 after the company filed 14 million share common stock offering, including warrants.
  • Vaxart, Inc. (NASDAQ: VXRT) fell 18% to $1.92 after dropping more than 18% on Monday.
  • OpGen, Inc. (NASDAQ: OPGN) dipped 16.8% to $2.8386.
  • BOQI International Medical Inc. (NASDAQ: BIMI) tumbled 16.5% to $4.175.
  • Altimmune, Inc. (NASDAQ: ALT) shares fell 15.8% to $2.66 after declining about 15% on Monday.
  • Precigen, Inc. (NASDAQ: PGEN) dropped 15.3% to $3.31 after the company reported worse-than-expected Q4 sales results.
  • iBio, Inc. (NYSE: IBIO) shares dipped 15% to $1.88. iBio highlighted withdrawal of proxy statement proposal related to amend its certificate of incorporation to authorize possible reverse stock split.
  • Tilray, Inc. (NASDAQ: TLRY) fell 14.1% to $13.19. Tilray reported a net loss of $219.2 million, or $2.14 a share for the fourth quarter, versus a year-ago loss of $31 million or $0.33 per share. The company also reported worse-than-expected Q4 sales.
  • Novavax, Inc. (NASDAQ: NVAX) fell 13.7% to $10.37. Novavax shares tumbled around 25% on Monday following news of a $150 million common stock offering via B. Riley FBR.
  • Vir Biotechnology, Inc. (NASDAQ: VIR) fell 13.4% to $39.05.
  • Titan International, Inc. (NYSE: TWI) dipped 13.4% to $1.8350.
  • Red Violet, Inc. (NASDAQ: RDVT) shares declined 13.3% to $22.97.
  • Co-Diagnostics, Inc. (NASDAQ: CODX) fell 13.1% to $15.47. Co-Diagnostics shares gained around 35% on Monday after the company announced it will provide COVID-19 tests to US CLIA labs.
  • GreenSky, Inc. (NASDAQ: GSKY) dropped 12.7% to $6.87.
  • Mallinckrodt plc (NYSE: MNK) shares declined 11.4% to $3.7397.
  • Nine Energy Service, Inc. (NYSE: NINE) slipped 11.3% to $3.15.
  • FlexShopper, Inc. (NASDAQ: FPAY) shares fell 10% to $2.6016.
  • Karyopharm Therapeutics Inc (NASDAQ: KPTI) fell 9.9% to $24.97 after the company announced a proposed public offering of common stock of $150 million.
  • OptimizeRx Corporation (NASDAQ: OPRX) shares dipped 9.5% to $7.34.
  • Axos Financial, Inc. (NYSE: AX) fell 8.8% to $23.66.
  • Cronos Group Inc. (NASDAQ: CRON) dropped 8.8% to $5.49. Cronos Group said Monday it has submitted a Form 12b-25 with the U.S. Securities and Exchange Commission to postpone the date of filing its annual report for 15 days.
  • Applied DNA Sciences, Inc. (NASDAQ: APDN) shares fell 7.5% to $4.79 after rising around 30% on Monday.

Related Articles (APDN + ALT)

View Comments and Join the Discussion!

Posted-In: Mid-Day MoversNews Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at